newdrugapprovals.org
AN IMPROVED PROCESS FOR THE PREPARATION OF DOLUTEGRAVIR
Aurobindo Pharma MD and CEO N. Govindarajan at a company research centre. “It [the transition] is purely driven by the need to get more into areas where there is scope for better profit margi…